ACCOUNTS - Final Accounts


Caseware UK (AP4) 2019.0.227 2019.0.227 2020-06-302020-06-307No description of principal activitytrue2019-07-01false2trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09796975 2019-07-01 2020-06-30 09796975 2018-07-01 2019-06-30 09796975 2020-06-30 09796975 2019-06-30 09796975 c:Director4 2019-07-01 2020-06-30 09796975 d:Buildings d:LongLeaseholdAssets 2019-07-01 2020-06-30 09796975 d:Buildings d:LongLeaseholdAssets 2020-06-30 09796975 d:Buildings d:LongLeaseholdAssets 2019-06-30 09796975 d:PlantMachinery 2019-07-01 2020-06-30 09796975 d:PlantMachinery 2020-06-30 09796975 d:PlantMachinery 2019-06-30 09796975 d:PlantMachinery d:OwnedOrFreeholdAssets 2019-07-01 2020-06-30 09796975 d:OfficeEquipment 2019-07-01 2020-06-30 09796975 d:OfficeEquipment 2020-06-30 09796975 d:OfficeEquipment 2019-06-30 09796975 d:OfficeEquipment d:OwnedOrFreeholdAssets 2019-07-01 2020-06-30 09796975 d:ComputerEquipment 2019-07-01 2020-06-30 09796975 d:ComputerEquipment 2020-06-30 09796975 d:ComputerEquipment 2019-06-30 09796975 d:ComputerEquipment d:OwnedOrFreeholdAssets 2019-07-01 2020-06-30 09796975 d:OtherPropertyPlantEquipment 2019-07-01 2020-06-30 09796975 d:OtherPropertyPlantEquipment 2020-06-30 09796975 d:OtherPropertyPlantEquipment 2019-06-30 09796975 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2019-07-01 2020-06-30 09796975 d:OwnedOrFreeholdAssets 2019-07-01 2020-06-30 09796975 d:PatentsTrademarksLicencesConcessionsSimilar 2020-06-30 09796975 d:PatentsTrademarksLicencesConcessionsSimilar 2019-06-30 09796975 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2020-06-30 09796975 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2019-06-30 09796975 d:CopyrightsPatentsTrademarksServiceOperatingRights 2020-06-30 09796975 d:CopyrightsPatentsTrademarksServiceOperatingRights 2019-06-30 09796975 d:CurrentFinancialInstruments 2020-06-30 09796975 d:CurrentFinancialInstruments 2019-06-30 09796975 d:CurrentFinancialInstruments d:WithinOneYear 2020-06-30 09796975 d:CurrentFinancialInstruments d:WithinOneYear 2019-06-30 09796975 d:ShareCapital 2020-06-30 09796975 d:ShareCapital 2019-06-30 09796975 d:SharePremium 2020-06-30 09796975 d:SharePremium 2019-06-30 09796975 d:RetainedEarningsAccumulatedLosses 2020-06-30 09796975 d:RetainedEarningsAccumulatedLosses 2019-06-30 09796975 c:OrdinaryShareClass1 2019-07-01 2020-06-30 09796975 c:OrdinaryShareClass1 2020-06-30 09796975 c:OrdinaryShareClass1 2019-06-30 09796975 c:OrdinaryShareClass2 2019-07-01 2020-06-30 09796975 c:OrdinaryShareClass2 2020-06-30 09796975 c:OrdinaryShareClass2 2019-06-30 09796975 c:FRS102 2019-07-01 2020-06-30 09796975 c:AuditExempt-NoAccountantsReport 2019-07-01 2020-06-30 09796975 c:FullAccounts 2019-07-01 2020-06-30 09796975 c:PrivateLimitedCompanyLtd 2019-07-01 2020-06-30 09796975 2 2019-07-01 2020-06-30 09796975 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2019-07-01 2020-06-30 09796975 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:OwnedIntangibleAssets 2019-07-01 2020-06-30 09796975 d:CopyrightsPatentsTrademarksServiceOperatingRights d:Right-of-useIntangibleAssets 2019-07-01 2020-06-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 09796975










ORTHOSON LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2020

 
ORTHOSON LIMITED
REGISTERED NUMBER: 09796975

BALANCE SHEET
AS AT 30 JUNE 2020

2020
2019
Note
£
£

Fixed assets
  

Intangible assets
 4 
116,645
153,862

Tangible assets
 5 
191,648
70,694

  
308,293
224,556

Current assets
  

Debtors: amounts falling due within one year
 6 
62,958
136,734

Cash at bank and in hand
 7 
1,447,294
247,100

  
1,510,252
383,834

Creditors: amounts falling due within one year
 8 
(50,673)
(45,608)

Net current assets
  
 
 
1,459,579
 
 
338,226

Total assets less current liabilities
  
1,767,872
562,782

  

Net assets
  
1,767,872
562,782


Capital and reserves
  

Called up share capital 
 9 
2,080
1,630

Share premium account
  
2,791,194
969,367

Profit and loss account
  
(1,025,402)
(408,215)

  
1,767,872
562,782


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

Page 1

 
ORTHOSON LIMITED
REGISTERED NUMBER: 09796975

BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2020

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




R E Simmonds
Director

Date: 12 November 2020

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
ORTHOSON LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020

1.


General information

Orthoson Limited is a private company, limited by share capital and incorporated in England and Wales. 
The address of its registered office is: The Magdalen Centre, 1 Robert Robinson Avenue, Oxford, Oxfordshire, OX4 4GA.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

  
2.2

Licence option

During the period ended  30 June 2016, the Company capitalised an option to license or assign certain pieces of intellectual property in the field of orthopaedic surgery on the basis that it is likely be of significant use to the business for the foreseeable future. Amortisation of the option to licence will begin, on a 25% declining balance basis, once commercialisation of the technology has begun.

 
2.3

Going concern

The directors have considered the impact of the global Covid-19 pandemic on the ability of the
company to continue trading for the foreseeable future. This review has included considering the
impact of the pandemic to the date of signing the financial statements and updating financial
projections and projections in respect of income and the company’s supply chain. Based on this
review and taken together with existing financing facilities the directors believe that the financial
statements have been prepared appropriately on the going concern basis.

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Comprehensive Income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
ORTHOSON LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020

2.Accounting policies (continued)

 
2.5

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Statement of Comprehensive Income in the same period as the related expenditure.

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.8

Development costs

Development costs are an intangible asset already being used to contribute to the development of the company’s technology. The Company will begin amortisation on a 25% declining balance basis.

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
ORTHOSON LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020

2.Accounting policies (continued)


2.9
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Leasehold improvements
-
100%
Plant & machinery
-
33%
Office equipment
-
100%
Computer equipment
-
33%
Lab equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.10

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.13

Interest income

Interest income is recognised in profit or loss using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 7 (2019 - 2).

Page 5

 
ORTHOSON LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020

4.


Intangible assets




Patents
Development
Licence option
Total

£
£
£
£



Cost


At 1 July 2019
125,100
68,750
5,000
198,850



At 30 June 2020

125,100
68,750
5,000
198,850



Amortisation


At 1 July 2019
27,800
17,188
-
44,988


Charge for the year on owned assets
24,325
12,891
-
37,216



At 30 June 2020

52,125
30,079
-
82,204



Net book value



At 30 June 2020
72,975
38,671
5,000
116,646



At 30 June 2019
97,300
51,562
5,000
153,862



Page 6

 


 
ORTHOSON LIMITED


 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020


5.


Tangible fixed assets






L/Term Leasehold Property
Plant & machinery
Office equipment
Computer equipment
Lab Equipment
Total

£
£
£
£
£
£



Cost or valuation


At 1 July 2019
11,619
25,087
1,887
35,181
11,286
85,060


Additions
-
118,505
196
17,032
55,199
190,932



At 30 June 2020

11,619
143,592
2,083
52,213
66,485
275,992



Depreciation


At 1 July 2019
3,873
5,575
539
3,441
938
14,366


Charge for the year on owned assets
7,746
25,095
1,544
14,399
21,194
69,978



At 30 June 2020

11,619
30,670
2,083
17,840
22,132
84,344



Net book value



At 30 June 2020
-
112,922
-
34,373
44,353
191,648



At 30 June 2019
7,746
19,512
1,348
31,740
10,348
70,694

Page 7

 
ORTHOSON LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020

6.


Debtors

2020
2019
£
£


Other debtors
34,064
21,064

Prepayments and accrued income
28,894
115,670

62,958
136,734



7.


Cash and cash equivalents

2020
2019
£
£

Cash at bank and in hand
1,447,294
247,100

1,447,294
247,100



8.


Creditors: Amounts falling due within one year

2020
2019
£
£

Trade creditors
25,509
20,913

Other taxation and social security
-
11,665

Other creditors
6,264
3,764

Accruals and deferred income
18,900
9,266

50,673
45,608



9.


Share capital

2020
2019
£
£
Allotted, called up and fully paid



2,074,655 (2019 - 1,626,922) Ordinary shares of £0.001 each
2,075
1,627
5,375 (2019 - 2,625) G2 Ordinary shares of £0.001 each
5
3

2,080

1,630

During the year 2,750 G2 Ordinary shares of £0.001 and 447,733 Ordinary shares of £0.001 were issued for a total consideration of £1,822,277.

Page 8

 
ORTHOSON LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020

10.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company  in an independently administered fund. The pension cost charge represents contributions payable by the Company  to the fund and amounted to £26,010 (2019 - £10,463) . Contributions totalling £6,263 (2019 - £3,761) were payable to the fund at the balance sheet date and are included in creditors.


11.


Controlling party

The Company is controlled by its directors.


Page 9